CN1122570A - 革宁息吐治疗手术后恶心呕吐的用途 - Google Patents
革宁息吐治疗手术后恶心呕吐的用途 Download PDFInfo
- Publication number
- CN1122570A CN1122570A CN94192028A CN94192028A CN1122570A CN 1122570 A CN1122570 A CN 1122570A CN 94192028 A CN94192028 A CN 94192028A CN 94192028 A CN94192028 A CN 94192028A CN 1122570 A CN1122570 A CN 1122570A
- Authority
- CN
- China
- Prior art keywords
- vomiting
- granisetron
- placebo
- treatment
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Treatment Of Sludge (AREA)
Abstract
Description
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9305593.7 | 1993-03-18 | ||
GB939305593A GB9305593D0 (en) | 1993-03-18 | 1993-03-18 | Pharmaceuticals |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1122570A true CN1122570A (zh) | 1996-05-15 |
CN1085079C CN1085079C (zh) | 2002-05-22 |
Family
ID=10732290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94192028A Expired - Lifetime CN1085079C (zh) | 1993-03-18 | 1994-09-29 | 革宁息吐治疗手术后恶心呕吐的用途 |
Country Status (21)
Country | Link |
---|---|
US (1) | US5952340A (zh) |
EP (1) | EP0689437B1 (zh) |
JP (2) | JP3792251B2 (zh) |
KR (1) | KR100315606B1 (zh) |
CN (1) | CN1085079C (zh) |
AP (1) | AP511A (zh) |
AT (1) | ATE230596T1 (zh) |
AU (1) | AU676032B2 (zh) |
CA (1) | CA2158354C (zh) |
CY (1) | CY2427B1 (zh) |
DE (1) | DE69431986T2 (zh) |
DK (1) | DK0689437T3 (zh) |
ES (1) | ES2188611T3 (zh) |
GB (1) | GB9305593D0 (zh) |
HK (1) | HK1012237A1 (zh) |
HU (1) | HU214629B (zh) |
IL (1) | IL109059A (zh) |
SG (1) | SG46724A1 (zh) |
TW (1) | TW312622B (zh) |
WO (1) | WO1994021257A1 (zh) |
ZA (1) | ZA941844B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813621A (zh) * | 2003-01-30 | 2012-12-12 | 赫尔辛医疗股份公司 | 帕洛诺司琼液体药物配方 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9412995D0 (en) * | 1994-06-28 | 1994-10-26 | Prendergast Kenneth F | Safety enhancing pharmaceutical compositions of an active indazole |
WO2003100091A1 (en) * | 2002-05-24 | 2003-12-04 | Epidauros Biotechnologie Ag | Means and methods for improved treatment using 'setrones' |
SE0203410D0 (sv) * | 2002-11-18 | 2002-11-18 | Astrazeneca Ab | New use |
TWI355936B (en) | 2003-02-18 | 2012-01-11 | Helsinn Healthcare Sa | Uses of palonosetron hydrochloride |
GB0328186D0 (en) * | 2003-12-05 | 2004-01-07 | West Pharm Serv Drug Res Ltd | Intranasal compositions |
JP6081102B2 (ja) * | 2012-08-10 | 2017-02-15 | テルモ株式会社 | 安定なグラニセトロン含有水性製剤 |
GB201618425D0 (en) * | 2016-11-01 | 2016-12-14 | Acacia Pharma Ltd | method |
JP2017077484A (ja) * | 2016-11-30 | 2017-04-27 | テルモ株式会社 | 安定なグラニセトロン含有水性製剤の包装体 |
GB201702250D0 (en) | 2017-02-10 | 2017-03-29 | Acacia Pharma Ltd | Method |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8525913D0 (en) * | 1985-10-21 | 1985-11-27 | Beecham Group Plc | Compounds |
DE3650772T2 (de) * | 1985-04-27 | 2003-04-03 | F. Hoffmann-La Roche Ag, Basel | Derivate von Indazole-3-carboxamide und -3-carboxylsäure |
GB8928837D0 (en) * | 1989-12-21 | 1990-02-28 | Beecham Group Plc | Pharmaceuticals |
US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
EP0916346A3 (en) * | 1991-09-20 | 2000-12-06 | Glaxo Group Limited | NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
-
1993
- 1993-03-18 GB GB939305593A patent/GB9305593D0/en active Pending
-
1994
- 1994-03-15 HU HU9502692A patent/HU214629B/hu unknown
- 1994-03-15 WO PCT/EP1994/000820 patent/WO1994021257A1/en active IP Right Grant
- 1994-03-15 DE DE69431986T patent/DE69431986T2/de not_active Revoked
- 1994-03-15 JP JP52064194A patent/JP3792251B2/ja not_active Expired - Lifetime
- 1994-03-15 ES ES94911178T patent/ES2188611T3/es not_active Expired - Lifetime
- 1994-03-15 AT AT94911178T patent/ATE230596T1/de not_active IP Right Cessation
- 1994-03-15 SG SG1996009426A patent/SG46724A1/en unknown
- 1994-03-15 US US08/525,521 patent/US5952340A/en not_active Expired - Lifetime
- 1994-03-15 DK DK94911178T patent/DK0689437T3/da active
- 1994-03-15 CA CA002158354A patent/CA2158354C/en not_active Expired - Lifetime
- 1994-03-15 KR KR1019950703945A patent/KR100315606B1/ko not_active IP Right Cessation
- 1994-03-15 AU AU63774/94A patent/AU676032B2/en not_active Expired
- 1994-03-15 EP EP94911178A patent/EP0689437B1/en not_active Revoked
- 1994-03-16 AP APAP/P/1994/000626A patent/AP511A/en active
- 1994-03-16 ZA ZA941844A patent/ZA941844B/xx unknown
- 1994-03-21 IL IL10905994A patent/IL109059A/en not_active IP Right Cessation
- 1994-04-06 TW TW083102963A patent/TW312622B/zh not_active IP Right Cessation
- 1994-09-29 CN CN94192028A patent/CN1085079C/zh not_active Expired - Lifetime
-
1998
- 1998-12-15 HK HK98113470A patent/HK1012237A1/xx not_active IP Right Cessation
-
2004
- 2004-02-25 CY CY0400013A patent/CY2427B1/xx unknown
-
2005
- 2005-12-13 JP JP2005359022A patent/JP2006083190A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813621A (zh) * | 2003-01-30 | 2012-12-12 | 赫尔辛医疗股份公司 | 帕洛诺司琼液体药物配方 |
Also Published As
Publication number | Publication date |
---|---|
CA2158354C (en) | 2004-07-13 |
CA2158354A1 (en) | 1994-09-29 |
HK1012237A1 (en) | 1999-07-30 |
IL109059A0 (en) | 1994-11-28 |
CY2427B1 (en) | 2004-11-12 |
WO1994021257A1 (en) | 1994-09-29 |
JP2006083190A (ja) | 2006-03-30 |
JPH08507774A (ja) | 1996-08-20 |
CN1085079C (zh) | 2002-05-22 |
HU214629B (hu) | 1998-04-28 |
SG46724A1 (en) | 1998-02-20 |
TW312622B (zh) | 1997-08-11 |
HUT73502A (en) | 1996-08-28 |
IL109059A (en) | 1996-11-14 |
GB9305593D0 (en) | 1993-05-05 |
AP511A (en) | 1996-07-26 |
DE69431986T2 (de) | 2003-11-06 |
DK0689437T3 (da) | 2003-04-28 |
AP9400626A0 (en) | 1994-04-30 |
AU6377494A (en) | 1994-10-11 |
ES2188611T3 (es) | 2003-07-01 |
HU9502692D0 (en) | 1995-11-28 |
US5952340A (en) | 1999-09-14 |
DE69431986D1 (de) | 2003-02-13 |
EP0689437A1 (en) | 1996-01-03 |
ZA941844B (en) | 1995-09-18 |
EP0689437B1 (en) | 2003-01-08 |
JP3792251B2 (ja) | 2006-07-05 |
ATE230596T1 (de) | 2003-01-15 |
AU676032B2 (en) | 1997-02-27 |
KR100315606B1 (ko) | 2002-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2320039C (en) | Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia | |
Smith et al. | Efficacy of esmolol versus alfentanil as a supplement to propofol-nitrous oxide anesthesia | |
US4588589A (en) | Antidiarrheal compositions and use thereof | |
US5426120A (en) | Pharmaceutical composition containing γ-hydroxybutyric acid or its lactone in the treatment of drug dependence and nutritional disorders | |
KR101900520B1 (ko) | 복합 조성물 | |
CN1085079C (zh) | 革宁息吐治疗手术后恶心呕吐的用途 | |
Semple et al. | Transdermal hyoscine with patient‐controlled analgesia | |
US4438138A (en) | Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone | |
US5990175A (en) | Prevention of migraine | |
Bailie et al. | Total intravenous anaesthesia for laparoscopy | |
Tsutaoka et al. | Superwarfarin and Glass Ingestion with Prolonged Coagulopathy Requiring High‐Dose Vitamin K1 Therapy | |
US5510390A (en) | Anti-hypertensive composition and methods of treatment | |
US4778785A (en) | Pharmaceutical composition for retarding and reducing cachexia | |
IL126199A (en) | Pharmaceutical preparation for administration through the nose for preventive treatment for delayed vomiting | |
Dean et al. | Bleeding associated with concurrent warfarin and metronidazole therapy | |
MXPA01010125A (es) | Combinacion de una preparacion para el tratamiento de la malaria. | |
US6559180B2 (en) | Nitroglycerin-menthol potentiation for treatment of angina | |
CN1263465A (zh) | 利用选择性5-羟色胺再摄取抑制剂治疗和预防心脏病 | |
HU207455B (en) | Method for producing pharmaceutical preparations suitable for treating postischemical heart-troubles containing captoprile and in given case thrombolitic agent | |
US4062974A (en) | Method for treating drepanocytosis | |
Nnebe-Agumadu et al. | Accidental hydroxyurea over-dosage in a child with sickle cell anemia: an African experience | |
US5081153A (en) | Sterile parenteral composition | |
IL34670A (en) | Pharmaceutical preparations containing 2-) 2,6-dichlorophenyl-amino (-1,3-diazacicopentane-) 2) and / or its acidic salt salts | |
US5997884A (en) | Compositions and method for treating migraine | |
KR100413717B1 (ko) | 레보부피바카인및임산부의마취제로서그것의용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HOFFMAN-LALUOAI LTD. Free format text: FORMER OWNER: SMITHKLINE BEECHAM PLC Effective date: 20011024 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20011024 Address after: Basel Applicant after: F. Hoffmann-La Roche AG Address before: England Applicant before: Smithkline Beecham PLC |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |
Expiration termination date: 20140315 Granted publication date: 20020522 |